Valuation Morepen Laboratories Limited NSE India S.E.
Stocks
MOREPENLAB
INE083A01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
15:05:09 17/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 89.82 INR | +6.69% |
|
+11.93% | +118.70% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Morepen Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,291 | 14,462 | 17,488 | 13,127 | 21,500 | 26,220 |
| Change | - | 237% | 20.93% | -24.94% | 63.79% | 21.95% |
| Enterprise Value (EV) 1 | 5,486 | 15,415 | 18,663 | 13,162 | 21,620 | 26,219 |
| Change | - | 180.98% | 21.07% | -29.48% | 64.27% | 21.27% |
| P/E | 12.8x | 15x | 18.7x | 33.4x | 22.4x | 21.8x |
| PBR | 1.51x | 3.4x | 3.02x | 1.74x | 2.54x | 2.27x |
| PEG | - | 0x | -2.12x | -0.6x | 0x | 1.3x |
| Capitalization / Revenue | 0.5x | 1.21x | 1.12x | 0.92x | 1.26x | 1.45x |
| EV / Revenue | 0.64x | 1.29x | 1.2x | 0.93x | 1.27x | 1.45x |
| EV / EBITDA | 8.19x | 12.5x | 13.9x | 19.2x | 14x | 16.2x |
| EV / EBIT | 14.9x | 15.7x | 15.8x | 23.5x | 15.8x | 18.1x |
| EV / FCF | -31.9x | -54.9x | -13x | -47.9x | -94x | -11.8x |
| FCF Yield | -3.13% | -1.82% | -7.71% | -2.09% | -1.06% | -8.51% |
| Dividend per Share 2 | - | - | - | - | - | 0.2 |
| Rate of return | - | - | - | - | - | 0.42% |
| EPS 2 | 0.7465 | 2.15 | 1.96 | 0.77 | 1.88 | 2.2 |
| Distribution rate | - | - | - | - | - | 9.09% |
| Net sales 1 | 8,584 | 11,980 | 15,558 | 14,220 | 17,019 | 18,116 |
| EBITDA 1 | 670.3 | 1,230 | 1,338 | 686.6 | 1,545 | 1,620 |
| EBIT 1 | 369 | 981.7 | 1,180 | 560.8 | 1,366 | 1,451 |
| Net income 1 | 335.8 | 970.9 | 1,017 | 386.8 | 961.6 | 1,180 |
| Net Debt 1 | 1,195 | 953.1 | 1,174 | 34.98 | 120.5 | -0.928 |
| Reference price 2 | 9.54 | 32.15 | 36.60 | 25.68 | 42.06 | 47.85 |
| Nbr of stocks (in thousands) | 449,826 | 449,826 | 477,826 | 511,169 | 511,169 | 547,954 |
| Announcement Date | 05/09/20 | 04/09/21 | 02/09/22 | 04/09/23 | 01/08/24 | 12/08/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 33.76x | 12.18x | 24.85x | 0.59% | 1,052B | ||
| 28.96x | - | - | 2.06% | 627B | ||
| 31.84x | 7.42x | 15.42x | 2.75% | 441B | ||
| 19.79x | 4.7x | 11.65x | 2.81% | 349B | ||
| 21.42x | 5.54x | 13.77x | 2.89% | 287B | ||
| 19.89x | 4.11x | 11.68x | 2.14% | 241B | ||
| 26.26x | 6.84x | 12.14x | 2.43% | 224B | ||
| 13.32x | 4.79x | 9.96x | 3.83% | 202B | ||
| -42.28x | 6.13x | 23.96x | 2.38% | 172B | ||
| Average | 17.00x | 6.46x | 15.43x | 2.43% | 399.46B | |
| Weighted average by Cap. | 24.17x | 8.04x | 17.73x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
- Valuation Morepen Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















